Grantopen🌐 United StatesRFA-CA-27-002

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

National Institutes of Health

Details?

Posted: Jun 3, 2026
Response deadline: Nov 10, 2026, 12:00 AM UTC (122d)
Type: Grant
Category: 93.394
Status: open
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: RFA-CA-27-002

Doc Type: synopsis
Opp Status: posted

Similar open solicitations

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
United States · Jun 3, 2026
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
United States · May 21, 2026
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
United States · May 21, 2026
Metastasis Research Network (U54 Clinical Trial Not Allowed)
United States · Jun 4, 2026
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
United States · May 21, 2026
Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed)
United States · Jun 8, 2026

Similar past solicitations

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
United States · Dec 16, 2024
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
United States · Dec 16, 2024
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
United States · Dec 16, 2024
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
United States · Dec 16, 2024
Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research Community in Advancing Medication Repurposing and Repositioning Efforts for Substance Use Disorders (SUDs) (U54 - Clinical Trials Not Allowed)
United States · Sep 24, 2025

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.